Analyst Reveals Undervalued Pharmaceutical Gem in Canada
Research Report
Four-Year Data on New Drug for Early AD Positive
Research Report
Rest of 2025 Rich With Catalysts for Immunotherapy Co.
Research Report
New Drug for Early AD Shown to be Efficacious, Safe
Research Report
Biotech Firm Uncovers Gene Therapy Breakthrough in Portugal
New Therapy for AATD Could be Best in Class
Research Report
Share Price Appreciation of Biotech Due Over Next Six Months
Research Report
Biotech Company Finds High-Impact Alzheimer's Therapy in Europe
Anavex Life Sciences Corp. (AVXL:NASDAQ) earned positive analyst coverage following new long-term data for blarcamesine in early Alzheimer's disease. Experts pointed to safety, durability, and potential approval pathways. Read more about what they said.Immunotherapy Company Finds Rare Cancer Breakthrough in U.S.
OS Therapies Inc. (OSTX:NYSEAMERICAN) announced that its lead drug OST-HER2 was granted Orphan Drug Designation by the FDA for osteosarcoma. Read how the designation could accelerate development and create new investor interest.Biotech Co. Has Promising AI-Accelerated Pipeline
Research Report
Rakovina Therapeutics Inc. (RKV:TSX.V) recently gained analyst coverage from First Berlin Equity Research. Read on to see why this company rates the stock a Buy. Biopharma Firm Discovers High-Impact CNS Therapy in U.S. With Breakthrough Results
Reviva Pharmaceuticals Holdings Inc. (RVPH: NASDAQ) is gaining attention with strong Phase 3 results for its lead CNS candidate, brilaroxazine. Here's what analysts are seeing in its long-term potential.Ascending Dose Trial of FABP5 Inhibitor to Read Out Soon
Research Report
Meanwhile, a representative from the company advancing the small molecule in the clinic is slated to speak about it at a conference this week, noted a D. Boral Capital report. Regenerative Medicine Firm OK'd To Advance Trial in T1D
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) says the Data Safety Monitoring Board supports the ongoing evaluation of the biotech's Cell Pouch Bio-hybrid Organ in this indication.Cell Pouch Co. Peer Aborts Program Using Like Device
Research Report
The implications for Cell Pouch, an implantable cell delivery vehicle, and the biotech behind it are positive, noted a Leede Financial Inc. report. New Jersey Pharma Co. Shares Positive Pediatric Study
Research Report
Aquestive Therapeutics Inc. (AQST:NASDAQ) recently reported that it completed New Drug Application (NDA) submission for Anaphylm and positive pediatric study data for the non-device-based epinephrine product candidate, noted an H.C. Wainwright & Co. research note. 
Streetwise Key Charts
